Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vander

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Neurology|January 26, 2005
Improvement of SSPE by intrathecal infusion of alpha-IFNI Wirguin, T Vander, T Brenner, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Multiple dose trial of the thromboxane synthase inhibitor furegrelate in normal subjectsJ S Mohrland, J T Vander Lugt, D B Lakings
The Journal of Infection|December 31, 2002
Listeria monocytogenes meningitis in a patient with chronic hepatitis C infection, treated by interferon alfa and ribavirinT Vander, M Medvedovsky, C Hallevy, et al.
Spinal Cord|February 3, 2005
Carbamazepine toxicity following Oxybutynin and Dantrolene administration: a case reportT Vander, H Odi, V Bluvstein, et al.
European Journal of Pharmacology|December 29, 1995
The vesicular monoamine transporter is not regulated by dopaminergic drug treatmentsT Vander Borght, M Kilbourn, T Desmond, et al.
Pediatric Transplantation|January 29, 2019
Oral ribavirin for paramyxovirus infection after alemtuzumab-containing reduced-intensity conditioning HCT regimenAlexandra Dreyzin, Marian G Michaels, Mark T Vander Lugt, et al.
Thorax|June 1, 1988
Propranolol inhalation challenge in relation to histamine response in children with asthmaJ Gerritsen, G H Koëter, L T Vander Weele, et al.
European Journal of Pharmacology|May 24, 1995
Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecificM Kilbourn, L Lee, T Vander Borght, et al.
The Pediatric Infectious Disease Journal|July 30, 2024
Nephrotoxicity of Intravenous Ganciclovir in Pediatric Hematopoietic Cell Transplant RecipientsKengo Inagaki, Mark T Vander Lugt, Daniel Riggsbee, et al.
Nuclear Medicine and Biology|May 1, 1996
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersM R Kilbourn, K A Frey, T Vander Borght, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Neurology|January 26, 2005
Improvement of SSPE by intrathecal infusion of alpha-IFNI Wirguin, T Vander, T Brenner, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Multiple dose trial of the thromboxane synthase inhibitor furegrelate in normal subjectsJ S Mohrland, J T Vander Lugt, D B Lakings
The Journal of Infection|December 31, 2002
Listeria monocytogenes meningitis in a patient with chronic hepatitis C infection, treated by interferon alfa and ribavirinT Vander, M Medvedovsky, C Hallevy, et al.
Spinal Cord|February 3, 2005
Carbamazepine toxicity following Oxybutynin and Dantrolene administration: a case reportT Vander, H Odi, V Bluvstein, et al.
European Journal of Pharmacology|December 29, 1995
The vesicular monoamine transporter is not regulated by dopaminergic drug treatmentsT Vander Borght, M Kilbourn, T Desmond, et al.
Pediatric Transplantation|January 29, 2019
Oral ribavirin for paramyxovirus infection after alemtuzumab-containing reduced-intensity conditioning HCT regimenAlexandra Dreyzin, Marian G Michaels, Mark T Vander Lugt, et al.
Thorax|June 1, 1988
Propranolol inhalation challenge in relation to histamine response in children with asthmaJ Gerritsen, G H Koëter, L T Vander Weele, et al.
European Journal of Pharmacology|May 24, 1995
Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecificM Kilbourn, L Lee, T Vander Borght, et al.
The Pediatric Infectious Disease Journal|July 30, 2024
Nephrotoxicity of Intravenous Ganciclovir in Pediatric Hematopoietic Cell Transplant RecipientsKengo Inagaki, Mark T Vander Lugt, Daniel Riggsbee, et al.
Nuclear Medicine and Biology|May 1, 1996
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersM R Kilbourn, K A Frey, T Vander Borght, et al.
Pageof 8